About Amhwa Biopharm
Cosmetic labs in China reach new standards with Amhwa Biopharm, operating from its facility at 488 Huanghe Road in Binzhou, Shandong. As China’s second-largest producer of hyaluronic acid, the company delivers:
- FDA-approved pharmaceutical ingredients
- cGMP-certified manufacturing processes
- Specialized HA derivatives for cosmetics
- Pharmaceutical-grade raw materials
From its Shandong base, Amhwa Biopharm supplies ingredients for cosmetics, food supplements, and medical applications across Asia and global markets.
Frequently asked questions
Amhwa Biopharm manufactures the following product categories:
- Hyaluronic Acid Products
- Pure hyaluronic acid
- Sodium hyaluronate
- HA derivatives
- Raw Materials for:
- Cosmetic formulations
- Food supplements
- Eye drop solutions
- Injectable products
The manufacturing process follows biotechnology protocols for pharmaceutical and cosmetic applications.
Amhwa Biopharm maintains the following quality and regulatory standards:
| Category | Details |
|---|---|
| Regulatory Compliance |
|
| Production Capacity |
|
| Quality Control |
|
Amhwa Biopharm operates from its manufacturing facility in China:
Manufacturing FacilityNumber 488 Huanghe 12 Road
Binzhou, Shandong
China, 256600
Market presence includes:
- Geographic Coverage
- Domestic Chinese market
- International exports
- Global supply chain integration
- Industry Sectors
- Cosmetic manufacturers
- Pharmaceutical companies
- Food supplement producers
More details about Amhwa Biopharm
A leading biotechnology firm in China
Amhwa Biopharm, established in 2010, has grown to become China’s second-largest manufacturer of hyaluronic acid and its derivatives. Operating as a cosmetic lab and pharmaceutical manufacturer, the company focuses on innovation and quality in biochemical production.
Specialized production capabilities
Based in Binzhou, Shandong Province, Amhwa Biopharm develops and manufactures sodium hyaluronate and HA derivatives for various applications. The company’s output serves multiple industries, including cosmetics, pharmaceuticals, and food sectors.
Product range and applications
- Cosmetic ingredients and formulations
- Pharmaceutical raw materials
- Eye drop solutions
- Injectable products
Quality standards and compliance
The facility maintains high manufacturing standards, as evidenced by its recent achievements in regulatory compliance. In October 2024, Amhwa Biopharm successfully passed the US FDA inspection with zero deficiencies, receiving the cGMP Inspection Report (EIR).
Strategic location and manufacturing facility
Located at 488 Huanghe 12 Road in Binzhou, the manufacturing site benefits from Shandong’s established pharmaceutical and biotechnology infrastructure. This positioning allows for efficient distribution across Asia and global markets.
Research and development focus
The company maintains active research programs in biotechnology, continuously advancing its capabilities in pharmaceutical manufacturing and cosmetic ingredient development. This commitment to innovation strengthens its position in both domestic and international markets.
Company gallery
